Loading company…
San Francisco AI company designing peptide therapeutics using generative models and physics-based molecular modeling.
Menten AI, Inc. was founded in 2018 in San Francisco, US, by Hans Melo and Tamás Görbe. Its generative AI platform designs peptide therapeutics, combining machine learning with physics-based modeling to address small datasets and hard-to-drug targets. It works with pharmaceutical and biotech companies on a B2B basis through collaborative agreements. In June 2020 it raised USD 4 million in seed funding from Khosla Ventures, Uncork Capital and other investors.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in